Skip to content

Sanara MedTech Inc. SMTI Deferred Tax Assets, Operating Loss Carryforwards

Deferred Tax Assets, Operating Loss Carryforwards at other companies

Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwards.

The official record: Sanara MedTech Inc.’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s deferred tax assets, operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s deferred tax assets, operating loss carryforwards?
Sanara MedTech Inc. (SMTI) reported deferred tax assets, operating loss carryforwards of $13.39M in Q4 2025.
How has Sanara MedTech Inc.'s deferred tax assets, operating loss carryforwards changed year-over-year?
Sanara MedTech Inc.'s deferred tax assets, operating loss carryforwards increased by 3.7% year-over-year, from $12.91M to $13.39M.
What is the long-term trend for Sanara MedTech Inc.'s deferred tax assets, operating loss carryforwards?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s deferred tax assets, operating loss carryforwards has grown at a 36.5% compound annual growth rate (CAGR), from $2.83M to $13.39M.